Answers Now: Personalizing Treatment for Metastatic Breast Cancer

In this replay of a recent Breast Cancer Answers Now program, Patient host, Pam Kohl, Founder, Komen Metastatic Breast Cancer Collaborative Research Initiative is joined by Erika Hamilton, MD, Director, Breast Cancer and Gynecologic Cancer Research Program, Sarah Cannon Research Institute to discuss the difference in treatment for metastatic breast cancer de novo vs recurrent patients.

© 2024 HealthCentral LLC. All rights reserved.

More Videos